Jeffrey LP, McCloskey WW, Rich DS, et al: Hospital restriction policy for newly marketed antimicrobial agents. Am J Hosp Pharm43:2230-2231, 1986
2.
Nickman NA, Blissenbach HF, Herrick JF: Medical committee enforcement of policy limiting postsurgical antibiotic use . Am J Hosp Pharm41:2053-2056, 1984
3.
Hayman JN, Sbravati EC: Controlling cephalosporin and aminoglycoside costs through pharmacy and therapeutics committee restrictions. Am J Hosp Pharm42:1343-1347, 1985
4.
Volger BW, Ross MB, Brunetti HR, et al: Compliance with a restricted antimicrobial agent policy in a university hospital. Am J Hosp Pharm45:1540-1544, 1988
5.
Briceland LL , Quintiliani R., Nightingale CH: Multidisciplinary cost-containment program promoting oral metronidazole for treatment of antibiotic associated colitis . Am J Hosp Pharm45:122-125, 1988
6.
Haas CE, Paladino JA, Dibona JR: Effect of a preprinted chart note on appropriate cefazolin prescribing. Am J Hosp Pharm43:1754-1756,1986
7.
Wright DB, Stankiewicz RF, Miller D.: Documenting pharmacist interventions on an infectious diseases service. Am J Hosp Pharm43:2229-2230,1986
8.
Von Seggern RL : Culture and antibiotic monitoring service in a community hospital. Am J Hosp Pharm44:1358-1362, 1987
9.
MacCosbe PE, Gartenberg G.: Modifying empiric antibiotic prescribing: Experience with one strategy in a medical residency program. Hosp Formul20:986-999, 1985
10.
Greene SA, Record KE, Rapp RP, et al: Pharmacy initiatives to reduce clindamycin use. Am J Hosp Pharm43:1210-1213, 1986
11.
Wein PJ, Hoffmann RP: Promoting the cost-effective utilization of cefoxitin with a drug use education program. Hosp Formul22:299-308, 1987
12.
Gupta S., Bachand RL, Jewesson PJ: Impact of a two stage intervention program on cefazolin usage at a major teaching hospital. Hosp Formul24:41-46, 1989
13.
Lyon RA, Nowell MJ: Effect of a P & T committee newsletter on antiinfective prescribing habits . Hosp Formul20:742-744, 1985
14.
Shalansky S. , Gupta S., Jewesson P.: Impact of a practical two-stage intervention on aminoglycoside usage. Hosp Formul24:332-341, 1989
15.
Quintiliani R., Cooper BW, Briceland LL, et al: Formulary replacement policies: Cefotetan vs cefoxitin. Inf Med Jul/Aug:275-279,1987
16.
Kowalski SF , Echols RM, Peck F.: Preprinted order sheet to enhance antibiotic prescribing and surveillance. Am J Hosp Pharm39:1528-1529,1982
17.
Echols RM, Kowalsky SF: The use of an antibiotic order form for antibiotic utilization review: Influence on physicians' prescribing patterns. J Infect Dis150:803-807, 1984
18.
Durbin WA Jr, Lopida B., Goldman DA: Improved antibiotic usage following introduction of a novel prescription system . JAMA246:1796-1800, 1981
19.
Quintiliani RQ, Nightingale CH: Economic impact of streamlining antibiotic administration. Am J Med82:391-395,1987
20.
Briceland LL , Nightingale CH, Quintiliani R, et at: Multidisciplinary cost containment program promoting less frequent administration of injectable mezlocillin . Am J Hosp Pharm45:1082-1085,1988
21.
Powell SH, Thompson WL, Luthe MA: Once daily vs continuous aminoglycoside dosing: Efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin and tobramycin. J Infect Dis147:918-932,1983
22.
Kapusnik JE , Hackbarth CJ, Chambers HF, et at: Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental Pseudomonas pneumonia . J Infect Dis158:7-12, 1988
